EXEL
Exelixis Inc
NASDAQ: EXEL · HEALTHCARE · BIOTECHNOLOGY
$44.69
-0.53% today
Updated 2026-04-29
Market cap
$11.35B
P/E ratio
16.08
P/S ratio
4.89x
EPS (TTM)
$2.78
Dividend yield
—
52W range
$34 – $50
Volume
2.7M
Exelixis Inc (EXEL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+30.0%
Last 4 quarters
Revenue YoY growth
+5.6%
Most recent quarter
EPS YoY growth
+76.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.9%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-19.0%
2025-07-28
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-10 | $0.97 | +21.2% | $43.95 | $42.94 | -2.3% |
| 2025-10-27 | $0.78 | +12.5% | $38.72 | $40.08 | +3.5% |
| 2025-07-28 | $0.75 | +17.2% | $45.60 | $36.94 | -19.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.80 | $0.97 | +21.2% | $598.66M | +5.6% |
| 2025-09-30 | $0.69 | $0.78 | +12.5% | $597.75M | +10.8% |
| 2025-06-30 | $0.64 | $0.75 | +17.2% | $568.26M | -10.8% |
| 2025-03-31 | $0.37 | $0.62 | +69.1% | $555.45M | +30.6% |
| 2024-12-31 | $0.49 | $0.55 | +11.8% | $566.75M | +18.2% |
| 2024-09-30 | $0.35 | $0.40 | +14.3% | $539.54M | +14.3% |
| 2024-06-30 | $0.30 | $0.77 | +156.7% | $637.18M | +35.6% |
| 2024-03-31 | $0.24 | $0.20 | -16.7% | $425.23M | — |
| 2023-12-31 | $0.21 | $0.27 | +28.6% | $479.65M | — |
| 2023-09-30 | $0.10 | $0.10 | +0.0% | $471.92M | — |
| 2023-06-30 | $0.16 | $0.25 | +56.3% | $469.85M | — |
Frequently asked questions
Has Exelixis Inc beaten earnings estimates?
Exelixis Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +30.0% over the last 4 quarters.
How does EXEL stock react to earnings?
EXEL stock has moved an average of -5.9% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Exelixis Inc's revenue growth rate?
Exelixis Inc reported year-over-year revenue growth of +5.6% in its most recent quarter, with EPS growing +76.4% year-over-year.